Search Results - "TAZAWA, R"
-
1
Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan
Published in The European respiratory journal (01-02-2011)Get full text
Journal Article -
2
Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infection
Published in Thorax (01-10-2009)“…Non-tuberculous mycobacterial lung disease, most commonly caused by Mycobacterium avium infection, tends to show variable disease progression, and significant…”
Get more information
Journal Article -
3
Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis
Published in The European respiratory journal (01-03-2012)Get full text
Journal Article -
4
Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene
Published in Biochemical and biophysical research communications (30-08-1994)“…Prostaglandin H synthase (PGHS) is the rate-limiting enzyme in the conversion of arachidonic acid to prostanoids. The human PGHS has two isoforms. PGHS-1 is a…”
Get more information
Journal Article -
5
0205 Remote Collection of Daily Life Information for Japanese Residents
Published in Sleep (New York, N.Y.) (27-05-2020)“…Abstract Introduction Japanese medical students spend their school days under a dense curriculum. It is often difficult to maintain their healthy lifestyle…”
Get full text
Journal Article -
6
Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma
Published in Cancer gene therapy (01-11-2000)“…Interleukin-2 (IL-2) and interleukin-12 (IL-12) are crucial cytokines that induce potent antitumor responses in a variety of animal cancer models. Although…”
Get full text
Journal Article -
7
-
8
-
9
Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in Japan
Published in American journal of respiratory and critical care medicine (01-04-2008)“…Acquired pulmonary alveolar proteinosis (PAP) is a syndrome characterized by pulmonary surfactant accumulation occurring in association with…”
Get full text
Journal Article -
10
-
11
A42 NEW DEVELOPMENTS IN ILD RESEARCH: Peripheral Alveolar Nitric Oxide Concentration Reflects Macrophage Inflammation Of Auto-Immune Pulmonary Alveolar ProteINOSis
Published in American journal of respiratory and critical care medicine (01-01-2017)“…Introduction Nitric oxide (NO) derived from the respiratory system has a deep relationship with the patho-etiology of respiratory diseases. Results After whole…”
Get full text
Journal Article -
12
C75 FIBROSIS: CURRENT AND FUTURE APPROACHES: Chronic Inhalation Of Recombinant Human Granulocyte/macrophage Colony Stimulating Factor (gm-Csf) And Gm-Csf Antibody In Nonhuman Primates
Published in American journal of respiratory and critical care medicine (01-01-2017)“…Conclusions: The present study demonstrated that the chronic inhalation of rhGM-CSF could induce neutralizing GM-CSF antibody in a group of nonhuman primates,…”
Get full text
Journal Article -
13
Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB
Published in Journal of medical genetics (01-03-2011)“…Disruption of granulocyte/macrophage colony-stimulating factor (GM-CSF) signalling causes pulmonary alveolar proteinosis (PAP). Rarely, genetic defects in…”
Get more information
Journal Article -
14
-
15
C44 DON'T PASS ME BY: PULMONARY ALVEOLAR PROTEINOSIS: Inhalation Of Recombinant Human Granulocyte/macrophage-Colony Stimulating Factor And Induction Of The Gm-Csf Antibody In Pulmonary Alveolar ProteINOSis
Published in American journal of respiratory and critical care medicine (01-01-2015)Get full text
Journal Article -
16
-
17
A35 I'VE GOT A FEELING WE'RE GOING TO SOLVE THIS ONE: INSIGHTS INTO LYMPHANGIOLEIOMYOMATOSIS: Eighteen Months Sirolimus Medication Benefits Not Only Patients With Moderate To Severe Lam But Also Those With Mild Disease
Published in American journal of respiratory and critical care medicine (01-01-2015)Get full text
Journal Article -
18
-
19
A43 NON-IPF ILD: CLINICAL STUDIES: Risk Factors For Stomatitis In Patients With Lymphangioleiomyomatosis During Treatment With Sirolimus: A Multicenter Investigator-Initiated Prospective Study
Published in American journal of respiratory and critical care medicine (01-01-2017)“…Multivariate Poisson regression analysis revealed that Hb level was the risk factor associated with the rate of stomatitis incidence among the baseline data…”
Get full text
Journal Article -
20